Position in SRRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$103,321,900
+$5,806,748 QoQ
Shares Held
1,878,580
-5.3% QoQ
Ownership
1.54%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#20
of 304 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polar Capital Holdings Plc holds $3,774,805,029 across 41 Biotechnology names. SRRK ranks #14 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELVN |
Enliven Therapeutics, Inc.
|
6,430,636 | $326,354,777 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
4,570,556 | $275,878,760 | |
| 3 | CYTK |
Cytokinetics Inc
|
2,253,649 | $191,988,358 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,663,632 | $184,713,060 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
6,606,945 | $173,234,097 | |
| 6 | ASND |
Ascendis Pharma A/S
|
616,908 | $164,541,701 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
2,063,609 | $153,697,598 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
482,751 | $145,322,533 |
All Filings in SRRK
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,321,900 | 1,878,580 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $97,515,152 | 1,983,628 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $58,234,584 | 1,322,011 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $29,571,613 | 794,082 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $53,130,000 | 1,500,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $83,055,377 | 2,583,371 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $117,055,794 | 2,708,371 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $23,554,782 | 2,940,672 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $24,495,797 | 2,940,672 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $52,226,334 | 2,940,672 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $55,284,633 | 2,940,672 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,663,674 | 1,501,926 | Shares | Defined | 2023-11-22 | |
| 2021-03-31 | $7,599,000 | 150,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $12,132,500 | 250,000 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||